Search results
Results from the Health.Zone Content Network
PSC develops slowly. You may have it for years before you notice any symptoms. Some of the signs are: Fatigue. Itchy skin. Yellowish skin and eyes caused by a condition called jaundice. As PSC ...
Primary sclerosing cholangitis (PSC) is a rare liver disease that affects the bile ducts. PSC is progressive, which means it gets worse over time. Treatment includes taking certain medications ...
Primary sclerosing cholangitis (PSC) is a long-term progressive disease of the liver and gallbladder characterized by inflammation and scarring of the bile ducts, which normally allow bile to drain from the gallbladder. Affected individuals may have no symptoms or may experience signs and symptoms of liver disease, such as yellow discoloration ...
Itching without rash can also be a side effect of certain medications, including opioids, statins, and blood pressure drugs. Skin conditions such as eczema and psoriasis cause itching accompanied ...
Outlook. Takeaway. Researchers have established a connection between primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). PSC is a rare condition that causes scarring in the bile ...
PSC does not parallel the onset, extent, duration, or activity of the colonic inflammation in ulcerative colitis. [34] In addition, colectomy does not have an impact on the course of primary sclerosing cholangitis in individuals with UC. [34] PSC is associated with an increased risk of colorectal cancer and cholangiocarcinoma (bile duct cancer).
8 min read. Primary biliary cholangitis (PBC) is a rare liver disease. It blocks and destroys bile ducts in the liver. Doctors used to call it “primary biliary cirrhosis.”. “Biliary” means ...
Male. Female. Continue. NEW: This symptom checker now includes the ability to select symptoms by body location. We hope this makes it easier for you to identify your symptoms and possible conditions. The tool also allows you to select multiple symptoms quickly. Click to see FAQs and tips for searching. Tell Us What You Think.